Clinical trial
Boston Lung Cancer Study (Formerly Molecular and Genetic Analysis of Lung Cancer)
NCT00471978 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Boston Lung Cancer Study (Formerly Molecular and Genetic Analysis of Lung Cancer)
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 30, 2005
- Completion date
- September 30, 2028
- Enrollment
- 15,000 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer